• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在门诊环境中对可穿戴式心脏复律除颤器进行适当电击。

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting.

作者信息

Kishihara Jun, Niwano Shinichi, Nakamura Hironori, Igarashi Tazuru, Ishizue Naruya, Fujiishi Tamami, Oikawa Jun, Murakami Masami, Fukaya Hidehira, Ako Junya

机构信息

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

出版信息

J Arrhythm. 2016 Feb;32(1):67-9. doi: 10.1016/j.joa.2015.08.003. Epub 2015 Sep 26.

DOI:10.1016/j.joa.2015.08.003
PMID:26949434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4759120/
Abstract

The wearable cardioverter-defibrillator (WCD) represents an alternative clinical approach to prevent sudden cardiac death as a bridge to therapy when making a final decision regarding the need for an implantable cardioverter defibrillator (ICD), especially in patients who are in the so-called gray zone according to ICD guidelines. Although the WCD system was introduced in Japan in April 2014, data regarding its usage and experience are limited. We report the first case of appropriate shock therapy using the WCD in an outpatient setting in Japan. We describe the case of a 22-year-old-woman who received the first case of successful appropriate WCD shock therapy in an outpatient setting in Japan.

摘要

可穿戴式心脏复律除颤器(WCD)是一种替代性的临床方法,用于预防心脏性猝死,作为在就是否需要植入式心脏复律除颤器(ICD)做出最终决定时的治疗桥梁,特别是对于那些根据ICD指南处于所谓灰色地带的患者。尽管WCD系统于2014年4月在日本引入,但其使用情况和经验数据有限。我们报告了日本门诊环境中首例使用WCD进行适当电击治疗的病例。我们描述了一名22岁女性的病例,她在日本门诊环境中接受了首例成功的WCD适当电击治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c621/4759120/6ee31258f1c5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c621/4759120/6ee31258f1c5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c621/4759120/6ee31258f1c5/gr1.jpg

相似文献

1
An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting.在门诊环境中对可穿戴式心脏复律除颤器进行适当电击。
J Arrhythm. 2016 Feb;32(1):67-9. doi: 10.1016/j.joa.2015.08.003. Epub 2015 Sep 26.
2
Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
J Cardiol. 2017 Jan;69(1):359-363. doi: 10.1016/j.jjcc.2016.08.004. Epub 2016 Sep 3.
3
Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.穿戴式心脏除颤器在心肌梗死后早期被认为高危患者中的应用。
J Am Coll Cardiol. 2013 Nov 19;62(21):2000-2007. doi: 10.1016/j.jacc.2013.05.086. Epub 2013 Jul 31.
4
Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.老年患者穿戴式除颤器的应用经验:来自穿戴式除颤器患者前瞻性注册研究的结果。
Heart Rhythm. 2018 Sep;15(9):1379-1386. doi: 10.1016/j.hrthm.2018.04.014. Epub 2018 Apr 18.
5
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).可穿戴式心脏除颤器在高危心脏患者中的应用:来自前瞻性可穿戴式心脏除颤器(WEARIT-II 注册研究)患者使用登记数据库的数据。
Circulation. 2015 Oct 27;132(17):1613-9. doi: 10.1161/CIRCULATIONAHA.115.015677. Epub 2015 Aug 27.
6
Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres.可穿戴式心脏复律除颤器的门诊治疗:荷兰两个中心的临床经验。
Neth Heart J. 2017 May;25(5):312-317. doi: 10.1007/s12471-017-0957-4.
7
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层:可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
8
Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.可穿戴除颤器在植入式除颤器取出后对患者的保护益处:来自国家登记处的结果。
JACC Clin Electrophysiol. 2017 Mar;3(3):243-250. doi: 10.1016/j.jacep.2016.09.002. Epub 2016 Nov 23.
9
Wearable Cardioverter Defibrillator - Initial Experience in the Outpatient Setting in Japan.可穿戴式心脏复律除颤器——日本门诊环境中的初步经验。
Circ Rep. 2020 Feb 20;2(3):137-142. doi: 10.1253/circrep.CR-20-0001.
10
Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.使用可穿戴式心脏复律除颤器移除植入式心脏复律除颤器(ICD)后预防门诊患者心源性猝死
Pacing Clin Electrophysiol. 2014 May;37(5):562-8. doi: 10.1111/pace.12319. Epub 2013 Dec 3.

引用本文的文献

1
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
J Arrhythm. 2021 Jun 2;37(4):709-870. doi: 10.1002/joa3.12491. eCollection 2021 Aug.
2
Wearable Cardioverter Defibrillator - Initial Experience in the Outpatient Setting in Japan.可穿戴式心脏复律除颤器——日本门诊环境中的初步经验。
Circ Rep. 2020 Feb 20;2(3):137-142. doi: 10.1253/circrep.CR-20-0001.

本文引用的文献

1
How should we use the wearable cardioverter-defibrillator in Japan?在日本我们应该如何使用可穿戴式心脏复律除颤器?
Circ J. 2014;78(12):2851-3. doi: 10.1253/circj.cj-14-1188. Epub 2014 Nov 11.
2
Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death.可穿戴式心脏复律除颤器在心脏性猝死高危患者中的应用价值。
Circ J. 2014;78(12):2987-9. doi: 10.1253/circj.cj-14-1098. Epub 2014 Oct 31.
3
Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
穿戴式心脏除颤器在心肌梗死后早期被认为高危患者中的应用。
J Am Coll Cardiol. 2013 Nov 19;62(21):2000-2007. doi: 10.1016/j.jacc.2013.05.086. Epub 2013 Jul 31.
4
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层:可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
5
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.可穿戴式除颤器的综合国家经验:事件发生率、依从性和生存率。
J Am Coll Cardiol. 2010 Jul 13;56(3):194-203. doi: 10.1016/j.jacc.2010.04.016.
6
Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).降低心律失常性猝死的短期高风险。可穿戴式心脏复律除颤器(WCD)的应用经验。
Pacing Clin Electrophysiol. 2010 Mar;33(3):353-67. doi: 10.1111/j.1540-8159.2009.02590.x. Epub 2009 Nov 2.
7
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.
8
Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD.在猝死高危患者中使用可穿戴式除颤器终止快速心律失常:WEARIT/BIROAD研究结果
Pacing Clin Electrophysiol. 2004 Jan;27(1):4-9. doi: 10.1111/j.1540-8159.2004.00378.x.